ONCY logo

Oncolytics Biotech (ONCY) Total Expenses

Annual Total Expenses

$25.03 M
+$4.33 M+20.93%

December 31, 2023


Summary


Performance

ONCY Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherONCYexpensesmetrics:

Quarterly Total Expenses

$7.25 M
+$1.47 M+25.36%

September 30, 2024


Summary


Performance

ONCY Quarterly Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherONCYexpensesmetrics:

Total Expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

ONCY Total Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+20.9%-11.9%
3 y3 years+31.7%+15.8%
5 y5 years+87.8%+15.8%

ONCY Total Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+20.9%-11.9%+56.3%
5 y5-yearat high+63.0%-11.9%+81.3%
alltimeall time-31.8%+6339.9%-36.7%+2477.8%

Oncolytics Biotech Total Expenses History

DateAnnualQuarterly
Sep 2024
-
$7.25 M(+25.4%)
Jun 2024
-
$5.79 M(-10.6%)
Mar 2024
-
$6.47 M(-0.5%)
Dec 2023
$25.03 M(+20.9%)
$6.50 M(-21.0%)
Sep 2023
-
$8.23 M(+54.7%)
Jun 2023
-
$5.32 M(+6.9%)
Mar 2023
-
$4.98 M(-20.5%)
Dec 2022
$20.69 M(-1.1%)
$6.26 M(+35.0%)
Sep 2022
-
$4.64 M(-1.9%)
Jun 2022
-
$4.73 M(-5.0%)
Mar 2022
-
$4.98 M(-15.8%)
Dec 2021
$20.93 M(+10.1%)
$5.91 M(+21.0%)
Sep 2021
-
$4.89 M(-10.7%)
Jun 2021
-
$5.48 M(+17.6%)
Mar 2021
-
$4.66 M(-24.8%)
Dec 2020
$19.00 M(+23.8%)
$6.19 M(+30.7%)
Sep 2020
-
$4.74 M(+18.4%)
Jun 2020
-
$4.00 M(-2.8%)
Mar 2020
-
$4.12 M(-20.4%)
Dec 2019
$15.35 M(+15.2%)
$5.17 M(+95.6%)
Sep 2019
-
$2.64 M(-32.1%)
Jun 2019
-
$3.89 M(+6.9%)
Mar 2019
-
$3.64 M(-12.3%)
Dec 2018
$13.33 M(+10.7%)
$4.15 M(+59.8%)
Sep 2018
-
$2.60 M(-9.0%)
Jun 2018
-
$2.85 M(-23.2%)
Mar 2018
-
$3.72 M(+2.0%)
Dec 2017
$12.04 M(+4.3%)
$3.65 M(+50.5%)
Sep 2017
-
$2.42 M(-25.3%)
Jun 2017
-
$3.24 M(+20.4%)
Mar 2017
-
$2.69 M(-31.2%)
Dec 2016
$11.55 M(+5.9%)
$3.92 M(+51.9%)
Sep 2016
-
$2.58 M(+27.0%)
Jun 2016
-
$2.03 M(-31.8%)
Mar 2016
-
$2.98 M(+12.5%)
Dec 2015
$10.90 M(-36.0%)
$2.65 M(+20.2%)
Sep 2015
-
$2.20 M(-30.5%)
Jun 2015
-
$3.17 M(+8.7%)
Mar 2015
-
$2.91 M(-13.1%)
Dec 2014
$17.05 M(-26.5%)
$3.35 M(-22.0%)
Sep 2014
-
$4.30 M(-1.6%)
Jun 2014
-
$4.37 M(-13.6%)
Mar 2014
-
$5.05 M(-9.6%)
Dec 2013
$23.21 M(-36.8%)
$5.59 M(-6.7%)
Sep 2013
-
$5.99 M(+19.6%)
Jun 2013
-
$5.01 M(-24.5%)
Mar 2013
-
$6.63 M(-22.9%)
Dec 2012
$36.70 M
$8.60 M(-7.9%)
Sep 2012
-
$9.34 M(-8.2%)
Jun 2012
-
$10.17 M(+18.8%)
DateAnnualQuarterly
Mar 2012
-
$8.56 M(-25.3%)
Dec 2011
$29.05 M(+50.7%)
$11.46 M(+77.2%)
Sep 2011
-
$6.47 M(-4.4%)
Jun 2011
-
$6.77 M(+62.9%)
Mar 2011
-
$4.16 M(-43.7%)
Dec 2010
$19.28 M(+34.9%)
$7.38 M(+90.8%)
Sep 2010
-
$3.87 M(-9.3%)
Jun 2010
-
$4.26 M(+10.7%)
Mar 2010
-
$3.85 M(-22.2%)
Dec 2009
$14.30 M(-16.0%)
$4.95 M(+101.2%)
Sep 2009
-
$2.46 M(-34.0%)
Jun 2009
-
$3.73 M(+16.5%)
Mar 2009
-
$3.20 M(-19.6%)
Dec 2008
$17.02 M(+8.0%)
$3.98 M(-2.4%)
Sep 2008
-
$4.07 M(-25.0%)
Jun 2008
-
$5.43 M(+56.3%)
Mar 2008
-
$3.48 M(-16.3%)
Dec 2007
$15.76 M(+15.3%)
$4.15 M(+6.2%)
Sep 2007
-
$3.91 M(+2.0%)
Jun 2007
-
$3.83 M(+2.4%)
Mar 2007
-
$3.74 M(-17.0%)
Dec 2006
$13.66 M(+24.3%)
$4.51 M(+35.2%)
Sep 2006
-
$3.34 M(+12.7%)
Jun 2006
-
$2.96 M(+3.7%)
Mar 2006
-
$2.85 M(-17.1%)
Dec 2005
$10.99 M(+7.1%)
$3.44 M(+14.3%)
Sep 2005
-
$3.01 M(+23.5%)
Jun 2005
-
$2.44 M(+14.8%)
Mar 2005
-
$2.13 M(+42.5%)
Dec 2004
$10.26 M(+107.0%)
$1.49 M(-49.1%)
Sep 2004
-
$2.93 M(+21.9%)
Jun 2004
-
$2.40 M(+11.6%)
Mar 2004
-
$2.15 M(+37.8%)
Dec 2003
$4.96 M(+11.8%)
$1.56 M(+12.1%)
Sep 2003
-
$1.39 M(+8.5%)
Jun 2003
-
$1.28 M(+67.7%)
Mar 2003
-
$765.90 K(-31.7%)
Dec 2002
$4.43 M(-3.8%)
$1.12 M(-20.8%)
Sep 2002
-
$1.42 M(+47.1%)
Jun 2002
-
$962.80 K(+2.9%)
Mar 2002
-
$936.00 K(-11.6%)
Dec 2001
$4.61 M(+38.1%)
$1.06 M(-37.9%)
Sep 2001
-
$1.71 M(+67.5%)
Jun 2001
-
$1.02 M(+23.4%)
Mar 2001
-
$825.00 K(+8.1%)
Dec 2000
$3.34 M(+758.9%)
$763.50 K(-38.6%)
Sep 2000
-
$1.24 M(+19.5%)
Jun 2000
-
$1.04 M(+269.7%)
Mar 2000
-
$281.40 K
Dec 1999
$388.60 K
-

FAQ

  • What is Oncolytics Biotech annual total expenses?
  • What is the all time high annual total expenses for Oncolytics Biotech?
  • What is Oncolytics Biotech annual total expenses year-on-year change?
  • What is Oncolytics Biotech quarterly total expenses?
  • What is the all time high quarterly total expenses for Oncolytics Biotech?
  • What is Oncolytics Biotech quarterly total expenses year-on-year change?

What is Oncolytics Biotech annual total expenses?

The current annual total expenses of ONCY is $25.03 M

What is the all time high annual total expenses for Oncolytics Biotech?

Oncolytics Biotech all-time high annual total expenses is $36.70 M

What is Oncolytics Biotech annual total expenses year-on-year change?

Over the past year, ONCY annual total expenses has changed by +$4.33 M (+20.93%)

What is Oncolytics Biotech quarterly total expenses?

The current quarterly total expenses of ONCY is $7.25 M

What is the all time high quarterly total expenses for Oncolytics Biotech?

Oncolytics Biotech all-time high quarterly total expenses is $11.46 M

What is Oncolytics Biotech quarterly total expenses year-on-year change?

Over the past year, ONCY quarterly total expenses has changed by -$978.40 K (-11.88%)